PCM
AGN

Prelude Capital Management’s Allergan Inc AGN Stock Holding History

Prelude Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-39,616
Closed -$8.42M – 2470
2014
Q4 		$8.42M Buy
39,616
+27,121
+217% +$5.39M 1.23% 6
2014
Q3 		$2.23M Buy
12,495
+2,945
+31% +$489K 0.31% 53
2014
Q2 		$1.62M Buy
9,550
+4,028
+73% +$627K 0.21% 90
2014
Q1 		$685K Buy
5,522
+2,592
+88% +$316K 0.09% 300
2013
Q4 		$325K Buy
2,930
+50
+2% +$4.78K 0.05% 480
2013
Q3 		$260K Hold
2,880
– – 0.04% 461
2013
Q2 		$243K Buy
+2,880
New +$299K 0.05% 404

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Prelude Capital Management's AGN Position: Q1 2015 in Review

Prelude Capital Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 39,616 shares — an estimated $8.42M sold.

Prelude Capital Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $8.42M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Prelude Capital Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Prelude Capital Management sold 39,616 Allergan Inc shares in Q1 2015, an estimated $8.42M.
  • Prelude Capital Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Prelude Capital Management's Allergan Inc position peaked at $8.42M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Prelude Capital Management's 13F filing for Q1 2015, filed 15 May 2015.